Search - tctmd.com

Displaying 1 - 20 of 79

Sort: Relevancy | Date

News Daily News

Weight Regained Within 18 Months of Stopping GLP-1 Drugs

Michael O'Riordan

January 08, 2026

News Daily News

Patients With Obesity Get Biggest Benefit from Evolocumab: FOURIER

Michael O'Riordan

December 12, 2025

News Daily News

PREVENT Risk Calculator’s Accuracy Varies by Healthcare System, Patient Factors

Michael O'Riordan

July 18, 2025

News Daily News

Wider Use of Polypills to Prevent CVD Could Save Millions of Lives by 2050

Todd Neale

July 16, 2025

News Daily News

Early Combo Therapy With Ezetimibe Lowers MACE Risk After MI

Michael O'Riordan

April 22, 2025

News Daily News

Topline Data Point to Promise for VERVE-102 Gene-Editing Therapy

Caitlin E. Cox

April 14, 2025

News Daily News

Weekend Warriors Also See Mortality Benefits With Exercise

Michael O'Riordan

April 10, 2025

News Daily News

High Lp(a) Levels Harmful in Patients With and Without ASCVD

Michael O'Riordan

February 27, 2024

News Daily News

Evolocumab Reduces MACE in Patients With and Without Multivessel CAD: FOURIER

Michael O'Riordan

February 08, 2024

News Daily News

Less Is More: Lp(a) Much More Atherogenic Than LDL

Michael O'Riordan

January 16, 2024

News Daily News

Diagnosing FH in Kids and Teens Should Happen Early: In Real Life, It Varies

Michael O'Riordan

December 19, 2023

News Daily News

‘Smoldering Epidemic’ of CVD Risk Factors in Middle-Aged Adults

Michael O'Riordan

November 21, 2023

News Daily News

Half of American Indian and Alaska Native Seniors Have CVD: Medicare Analysis

L.A. McKeown

September 25, 2023

News Daily News

USPSTF: Screening Kids for Lipid Disorders Still Needs More Data

Shelley Wood

July 18, 2023

News Daily News

‘Code Blue’ for the Dire CVD Health Status of Most US Adults

Michael O'Riordan

July 05, 2022

News Daily News

Another Study Links Stopping Statins to MACE in the Elderly

Shelley Wood

December 03, 2021

News Daily News

Post-ACS Patients With Low LDL Levels Remain at Risk: IMPROVE-IT

Michael O'Riordan

October 04, 2021

News Daily News

Heterozygous FH Diagnosed Late, Remains Undertreated

Michael O'Riordan

September 13, 2021

News Daily News

Statins Positively Alter Coronary Plaque Composition

Michael O'Riordan

August 23, 2021

News Daily News

Latest Statin Risk-Benefit Analysis: More Harm Than Good?

Yael L. Maxwell

July 15, 2021

Advertisement

Weight Regained Within 18 Months of Stopping GLP-1 Drugs

Patients With Obesity Get Biggest Benefit from Evolocumab: FOURIER

PREVENT Risk Calculator’s Accuracy Varies by Healthcare System, Patient Factors

Wider Use of Polypills to Prevent CVD Could Save Millions of Lives by 2050

Early Combo Therapy With Ezetimibe Lowers MACE Risk After MI

Topline Data Point to Promise for VERVE-102 Gene-Editing Therapy

Weekend Warriors Also See Mortality Benefits With Exercise

High Lp(a) Levels Harmful in Patients With and Without ASCVD

Evolocumab Reduces MACE in Patients With and Without Multivessel CAD: FOURIER

Less Is More: Lp(a) Much More Atherogenic Than LDL

Diagnosing FH in Kids and Teens Should Happen Early: In Real Life, It Varies

‘Smoldering Epidemic’ of CVD Risk Factors in Middle-Aged Adults

Half of American Indian and Alaska Native Seniors Have CVD: Medicare Analysis

USPSTF: Screening Kids for Lipid Disorders Still Needs More Data

‘Code Blue’ for the Dire CVD Health Status of Most US Adults

Another Study Links Stopping Statins to MACE in the Elderly

Post-ACS Patients With Low LDL Levels Remain at Risk: IMPROVE-IT

Heterozygous FH Diagnosed Late, Remains Undertreated

Statins Positively Alter Coronary Plaque Composition

Latest Statin Risk-Benefit Analysis: More Harm Than Good?

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content